The Week in Review: Nov 23 – Nov 30, 2018

Friday, Nov 30, 2018 News Recap: Phil Wilkin: 1957 – 2018: R.I.P. R.I.P. Philip Wilkin. You gave so much to so many and asked for so little in return.  Saying such sad farewells today to our Board Member, Phil Wilkin, who passed away unexpectedly on Saturday, Nov. 24, 2018. Novel Surrogate End Point Proposed in Hepatocellular Carcinoma New research on patients with intermediate hepatocellular carcinoma (HCC) who have undergone conventional trans...

Novel Surrogate End Point Proposed in Hepatocellular Carcinoma

New research on patients with intermediate hepatocellular carcinoma (HCC) who have undergone conventional transarterial chemoembolization (cTACE) suggests that the duration of a response to a treatment, rather than the robustness of the response, may be a better predictor of overall survival. The study was published in JAMA Network Open. This novel surrogate end point, dubbed sustained response duration (SRD), was defined as the time between when a comple